Rochester, MN, United States of America

Scott E Strome

USPTO Granted Patents = 21 


 

Average Co-Inventor Count = 2.7

ph-index = 13

Forward Citations = 529(Granted Patents)


Location History:

  • Baltimore, MD (US) (2018 - 2021)
  • Reisterstown, MD (US) (2012 - 2022)
  • Rochester, MN (US) (2000 - 2024)

Company Filing History:


Years Active: 2000-2024

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Scott E. Strome: A Pioneering Innovator in Cancer Treatment

Introduction

Scott E. Strome is a highly regarded inventor and researcher based in Rochester, MN, USA. He has made significant contributions to the field of oncology, holding an impressive portfolio of 21 patents. His work focuses on advancements in cancer diagnosis and treatment, particularly in understanding the mechanisms that drive tumor aggressiveness and therapeutic targets.

Latest Patents

Among his latest inventions are two notable patents that showcase his innovative approaches to cancer management. The first, titled "Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target," outlines methods for diagnosing cancer by assessing B7-H1 expression in tissue samples. This patent also includes methods of treatment with agents that interfere with B7-H1-receptor interaction, identifies candidate subjects likely to benefit from cancer immunotherapy, and proposes methods for inhibiting the expression of B7-H1.

The second patent, "Universal antibody-mediated biosensor," introduces a groundbreaking biosensor cell line designed to detect target agents in various samples. The biosensor features a novel chimeric fusion protein capable of binding to any antibody's Fc region, allowing for universal detection of selected antigens through cellular activation.

Career Highlights

Scott E. Strome has had a distinguished career, holding positions at prestigious institutions such as Mayo Foundation for Medical Education and Research and the University of Maryland, Baltimore. His innovative spirit and dedication to the field of cancer research have positioned him as a leader in the academic and medical communities.

Collaborations

Throughout his career, Scott has collaborated with esteemed colleagues such as Lieping Chen and Dan H. Schulze. These partnerships have led to numerous advancements in the understanding and treatment of cancer, further amplifying the impact of his research.

Conclusion

With an extensive patent portfolio and a focus on groundbreaking cancer research, Scott E. Strome continues to influence the landscape of oncology. His inventions, especially in diagnostic methods and therapeutic strategies, hold potential for significant advancements in improving patient outcomes. As he progresses in his career, Scott E. Strome stands as a testament to the power of innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…